BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 25840538)

  • 1. Plasma is the physiologic buffer of tissue plasminogen activator-mediated fibrinolysis: rationale for plasma-first resuscitation after life-threatening hemorrhage.
    Moore HB; Moore EE; Gonzalez E; Wiener G; Chapman MP; Dzieciatkowska M; Sauaia A; Banerjee A; Hansen KC; Silliman C
    J Am Coll Surg; 2015 May; 220(5):872-9. PubMed ID: 25840538
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Shock-induced systemic hyperfibrinolysis is attenuated by plasma-first resuscitation.
    Moore HB; Moore EE; Morton AP; Gonzalez E; Fragoso M; Chapman MP; Dzieciatkowska M; Hansen KC; Banerjee A; Sauaia A; Silliman CC
    J Trauma Acute Care Surg; 2015 Dec; 79(6):897-903; discussion 903-4. PubMed ID: 26680132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of resuscitation fluids, fresh frozen plasma and antifibrinolytics on fibrinolysis in a thrombelastography-based, in-vitro, whole-blood model.
    Kostousov V; Wang YW; Cotton BA; Wade CE; Holcomb JB; Matijevic N
    Blood Coagul Fibrinolysis; 2013 Jul; 24(5):489-97. PubMed ID: 23406662
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Freeze-dried plasma enhances clot formation and inhibits fibrinolysis in the presence of tissue plasminogen activator similar to pooled liquid plasma.
    Huebner BR; Moore EE; Moore HB; Sauaia A; Stettler G; Dzieciatkowska M; Hansen K; Banerjee A; Silliman CC
    Transfusion; 2017 Aug; 57(8):2007-2015. PubMed ID: 28500652
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hemoglobin-based oxygen carriers promote systemic hyperfibrinolysis that is both dependent and independent of plasmin.
    Morton AP; Moore EE; Moore HB; Gonzalez E; Chapman MP; Peltz E; Banerjee A; Silliman C
    J Surg Res; 2017 Jun; 213():166-170. PubMed ID: 28601310
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fibrinolysis shutdown phenotype masks changes in rodent coagulation in tissue injury versus hemorrhagic shock.
    Moore HB; Moore EE; Lawson PJ; Gonzalez E; Fragoso M; Morton AP; Gamboni F; Chapman MP; Sauaia A; Banerjee A; Silliman CC
    Surgery; 2015 Aug; 158(2):386-92. PubMed ID: 25979440
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of colloid and crystalloid solutions on endogenous activation of fibrinolysis and resistance of polymerized fibrin to recombinant tissue plasminogen activator added ex vivo.
    Mittermayr M; Streif W; Haas T; Fries D; Velik-Salchner C; Klingler A; Innerhofer P
    Br J Anaesth; 2008 Mar; 100(3):307-14. PubMed ID: 18158312
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of Blood Components and Whole Blood in a Model of Severe Trauma-Induced Coagulopathy.
    Stettler GR; Moore EE; Nunns GR; Kelher M; Banerjee A; Silliman CC
    J Surg Res; 2021 Mar; 259():55-61. PubMed ID: 33278796
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 14-Day thawed plasma retains clot enhancing properties and inhibits tPA-induced fibrinolysis.
    Huebner BR; Moore EE; Moore HB; Shepherd-Singh R; Sauaia A; Stettler GR; Nunns GR; Silliman CC
    J Surg Res; 2017 Nov; 219():145-150. PubMed ID: 29078874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Southern copperhead venom enhances tissue-type plasminogen activator induced fibrinolysis but does not directly lyse human plasma thrombi.
    Nielsen VG
    J Thromb Thrombolysis; 2016 Jul; 42(1):33-7. PubMed ID: 26407681
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasmin thrombelastography rapidly identifies trauma patients at risk for massive transfusion, mortality, and hyperfibrinolysis: A diagnostic tool to resolve an international debate on tranexamic acid?
    Barrett CD; Moore HB; Vigneshwar N; Dhara S; Chandler J; Chapman MP; Sauaia A; Moore EE; Yaffe MB
    J Trauma Acute Care Surg; 2020 Dec; 89(6):991-998. PubMed ID: 33230046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of platelet count on clot retraction and tissue plasminogen activator-induced fibrinolysis on thrombelastography.
    Katori N; Tanaka KA; Szlam F; Levy JH
    Anesth Analg; 2005 Jun; 100(6):1781-1785. PubMed ID: 15920213
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma-based assays distinguish hyperfibrinolysis and shutdown subgroups in trauma-induced coagulopathy.
    Lawson MA; Holle LA; Dow NE; Hennig G; de Laat B; Moore HB; Moore EE; Cohen MJ; Bouchard BA; Freeman K; Wolberg AS
    J Trauma Acute Care Surg; 2022 Nov; 93(5):579-587. PubMed ID: 35687811
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma tissue-type plasminogen activator increases fibrinolytic activity of exogenous urokinase-type plasminogen activator.
    Shenkman B; Livnat T; Budnik I; Tamarin I; Einav Y; Martinowitz U
    Blood Coagul Fibrinolysis; 2012 Dec; 23(8):729-33. PubMed ID: 22918041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Haemodilution-induced profibrinolytic state is mitigated by fresh-frozen plasma: implications for early haemostatic intervention in massive haemorrhage.
    Bolliger D; Szlam F; Levy JH; Molinaro RJ; Tanaka KA
    Br J Anaesth; 2010 Mar; 104(3):318-25. PubMed ID: 20133450
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The α-globin chain of hemoglobin potentiates tissue plasminogen activator induced hyperfibrinolysis in vitro.
    Morton AP; Hadley JB; Ghasabyan A; Kelher MR; Moore EE; Bevers S; Dzieciatkowska M; Hansen KC; Cohen MS; Banerjee A; Silliman CC
    J Trauma Acute Care Surg; 2022 Jan; 92(1):159-166. PubMed ID: 34538821
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differentiating Pathologic from Physiologic Fibrinolysis: Not as Simple as Conventional Thrombelastography.
    Moore HB; Barrett CD; Moore EE; Pieracci FM; Sauaia A
    J Am Coll Surg; 2024 Jul; 239(1):30-41. PubMed ID: 38299576
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The in-vitro effect of fibrinogen, factor XIII and thrombin-activatable fibrinolysis inhibitor on clot formation and susceptibility to tissue plasminogen activator-induced fibrinolysis in hemodilution model.
    Shenkman B; Livnat T; Lubetsky A; Tamarin I; Budnik I; Einav Y; Martinowitz U
    Blood Coagul Fibrinolysis; 2012 Jul; 23(5):370-8. PubMed ID: 22498982
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of coagulation and fibrinolysis in Irish Wolfhounds and age-matched control dogs using tissue plasminogen activator-augmented viscoelastic testing.
    Davis S; Fletcher DJ; Newman A; Brooks MB
    J Vet Emerg Crit Care (San Antonio); 2024; 34(3):222-230. PubMed ID: 38775137
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 28-day thawed plasma maintains α
    Stettler GR; Moore EE; Huebner BR; Nunns GR; Moore HB; Coleman JR; Kelher M; Banerjee A; Silliman CC
    Vox Sang; 2021 Feb; 116(2):181-189. PubMed ID: 32894784
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.